OTHER
Evaluation of COVID-19 Vaccines: Is Hesitancy for Some Vaccines Evidence-Based ?
This discussion examines the complexities of comparing COVID-19 vaccines and the factors contributing to public hesitancy. It underscores why efficacy percentages alone can be misleading, pointing to differences in trial settings, population demographics, and circulating variants. Although rare side effects like blood clots have caused concern, the risk of severe COVID-19 remains significantly higher. The content emphasizes the importance of context-driven decision-making and encourages a more informed and balanced understanding of vaccine safety and effectiveness.
Already have an account? Log in
Part of an association? Click here, you may already have full access!
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
